Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
PeproMene Bio announced study demonstrating strong polyfunctionality of novel…
Researchers used a single-cell platform, which found that PMB-CT01 CAR T cells, had more polyfunctionality, which is T cells' ability to perform several functions at the same time, than CD 19 CAR T cells. PMB-CT01 cells also produced more stimulatory cytokines, which can spur the immune system, and effector cytokines, which can directly kill cancer cells. Researchers used a single-cell platform, which found that PMB-CT01 CAR T cells, had more polyfunctionality, which is T cells' ability to...
PR Newswire
07/08/2024
Glucose Monitoring Devices Market to Reach $38.9 Billion, Globally, by 2033 at…
Request Sample of the Report on Glucose Monitoring Devices Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A62953 Request Sample of the Report on Glucose Monitoring Devices Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A62953 Prime determinants of growth Rise in incidences of diabetes, favorable regulatory scenario, and growing awareness regarding the availability of various glucose monitoring devices are the major factors...
PR Newswire
07/08/2024
In Vitro Fertilization Market worth $1,650 million by 2029 driven by…
Browse in-depth TOC on "In Vitro Fertilization Market" Browse in-depth TOC on "In Vitro Fertilization Market" 249 - Tables52 - Figures280 - Pages CooperSurgical Inc.: Comprehensive Leader in IVF Solutions CooperSurgical Inc., based in the US, is a leading provider of a wide range of products and services for reproductive health professionals. Their extensive portfolio includes advanced equipment and technologies crucial for all phases of in vitro fertilization (IVF),...
PR Newswire
07/08/2024
Forensic Equipment and Supplies Market to Reach $16.5 Billion, Globally, by 2033…
Request Sample of the Report on Forensic Equipment and Supplies Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A09493 Request Sample of the Report on Forensic Equipment and Supplies Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A09493 Prime determinants of growth Increasing incidences of crime, rise in awareness and emphasis on forensic science in criminal investigations, and expanding application of forensic science are...
PR Newswire
07/08/2024
Functional Service Providers (FSP) Market 2024-2031 | Transform Your Business…
The Functional Service Providers (FSP) market is an element of the pharmaceutical and clinical research industry that provides services and resources to support various tasks in drug development and clinical trials. Clinical monitoring, statistical control, biostatistics, pharmacovigilance, scientific writing, and regulatory affairs are typical services provided by FSP groups. FSPs address a wide range of demands, including clinical operations, data administration, biostatistics, regulatory…
PR Newswire
07/08/2024
C2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together…
"Alzheimer's disease is on the rise, making it essential to innovate by offering less invasive and more accessible diagnostic procedures for patients," said Unilabs' Head of Innovation Dr. Rahul Chaudhary. "All too often, diagnosing Alzheimer's has been painful, invasive and expensive. This partnership will transform the diagnostic experience for patients with cognitive concerns while revolutionizing early diagnosis, and research efforts, and positively impacting long-term…
PR Newswire
07/08/2024
Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose…
AID systems improve health outcomes while reducing the burden of constant decision-making for people with diabetes who use intensive insulin as part of their overall therapy. AID systems can benefit people with both Type 1 and Type 2 diabetes who require multiple daily injections of rapid-acting insulin, currently estimated at more than 11 million people globally2. AID systems improve health outcomes while reducing the burden of constant decision-making for people with diabetes who use...
PR Newswire
07/08/2024
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and…
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody ®sonelokimab in hidradenitis suppurativa (“HS”), with topline results anticipated as of mid-2025Secured positive feedback from both U.S. Food and Drug Administration (“FDA”) and the E.U. European Medicines Agency (“EMA”) on the regulatory path for the Phase 3 program of the Nanobody ®sonelokimab in...
Nasdaq GlobeNewswire
07/08/2024
Ultimovacs Announces Notice of Resignation from Deputy Board Member
Oslo, August 7, 2024:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI) today announced that it has received notice from deputy board member Ketil Fjerdingen that he has resigned from his position as deputy member of the Company's Board of Directors.The Company wishes to thank Ketil Fjerdingen for his service to the Company over the years.For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASAEmail:...
Nasdaq GlobeNewswire
07/08/2024
AI that Detects Hidden Heart Disease is a Finalist for British Heart…
Caristo is proud to announce that the BHF-funded project that led to the creation of the company and the development of the CaRi-Heart® AI technology, is one of the three candidates for the award. Caristo is proud to announce that the BHF-funded project that led to the creation of the company and the development of the CaRi-Heart® AI technology, is one of the three candidates for the award. TheCaRi-Hearttechnology applies advanced AI algorithms to routine heart coronary computed...
PR Newswire
07/08/2024
Suppository Packaging Market worth $428 million by 2029 - Exclusive Report by…
Browse in-depth TOC on "Suppository Packaging Market". Browse in-depth TOC on "Suppository Packaging Market". 220 – Tables 45 – Figures 240 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8869604 "Aluminum/PE is the second largest material of the suppository packaging, in terms of value" Aluminum/PE material effectively minimizes the risk of suppositories from moisture, oxygen, light and other factors leading to...
PR Newswire
07/08/2024
Global Retail Industry - Insights around Market Size, Key Trends and Forecast…
The global athleisure market size was USD 358.07 billion in 2023 and is projected to grow at a CAGR of 9.3% from 2024 to 2030. The growing enthusiasm for sports and outdoor recreational activities among the young population is expected to drive the demand for athleisure. A key factor contributing to this trend is the increasing awareness of fitness and health, boosting the need for comfortable and stylish clothing. The global athleisure market size wasUSD 358.07 billionin 2023 and is...
PR Newswire
07/08/2024
Photocure ASA: Results for the second quarter of 2024
Photocure reported total group revenues of NOK 145.4 million in the second quarter of 2024 (NOK 144.3 million), and EBITDA* of NOK 27.8 million (NOK 23.4 million), driven by revenue growth and a milestone payment from Asieris for the NDA acceptance of Cevira® in China. Hexvix/Cysview revenues were NOK 122.4 million in the quarter (Q2 2023: NOK 115.9 million). The EBIT was NOK 20.7 million (NOK 16.8 million) and the cash balance at the end of the period was NOK 267.0 million. Photocure…
PR Newswire
07/08/2024
Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer
“We're thrilled to welcome Dr. Kilcoyne to Cellectis. He is a strategic, forward-thinking drug developer who is passionate about delivering life-saving therapies to patients. His clinical vision and proven leadership, as well as his extensive experience, will strengthen our clinical development efforts as we advance our product pipeline of next-generation CAR T-cell therapies,” said André Choulika, Ph.D., Chief Executive Officer at Cellectis.Before joining Cellectis, Dr. Kilcoyne was...
Nasdaq GlobeNewswire
07/08/2024
Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant…
Bagsværd, 7 August 2024 - Financial report for the period 1 January 2024 to 30 June 2024 Operating profit increased by 18% in Danish kroner and by 19% at constant exchange rates (CER) to DKK 57.8 billion. Operating profit is impacted by the impairment loss related to ocedurenone of DKK 5.7 billion.Sales in North America Operations increased by 36% in Danish kroner (36% at CER). Sales growth in the US was positively impacted by gross-to-net sales adjustments related to prior years...
Nasdaq GlobeNewswire
07/08/2024
Cellectis Provides Financial Results for the Second Quarter 2024
ODD and RPDD granted by the FDA and ODD granted by the European Commission to UCART22 for the treatment of ALL ODD granted by the FDA to CLLS52 (alemtuzumab) for ALL treatment Cash position of $273 million as of June 30, 2024 1 ; cash runway projection into 2026 NEW YORK, Aug.06, 2024(GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving...
Nasdaq GlobeNewswire
06/08/2024
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating…
REGULATED INFORMATIONNyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results FDA regulatory submission complete, U.S. approval on track for end of 2024 U.S. commercial launch fully funded with over €85 million in new capital raisedMont-Saint-Guibert, Belgium – August 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of...
Nasdaq GlobeNewswire
06/08/2024
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2024
AggregatedpresentationbydayandbymarketPurchases of own shares from July 29th to August 2nd, 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1129/07/2024FR00102591509 651103,2608XPARIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
06/08/2024
NTG Nordic Transport Group publishes interim report for H1 2024
Company announcement no. 7 – 24 6 August 2024 NTG Nordic Transport Group publishes interim report for H1 2024The interim report for H1 2024 is enclosed.In connection with publication of the results for H1 2024, a conference call will be hosted on 7 August 2024 at 10:00 AM CEST.The conference call will be held in English and can be followed live via NTG's website ; investor.ntg.com. Additional information For additional information, please contact: Investor relations and...
Nasdaq GlobeNewswire
06/08/2024
Bone Conduction Headphones Market Size to Grow USD 3671.9 Million by 2030 at a…
Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-26S15469/Global_and_India_Bone_Conduction_Headphones_Market_Report_Forecast_2023_2029 Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-26S15469/Global_and_India_Bone_Conduction_Headphones_Market_Report_Forecast_2023_2029 Major Factors Driving the Growth of Bone Conduction Headphones Market: The market for bone conduction headphones is expanding rapidly because consumers...
PR Newswire
06/08/2024
Single-Cell Analysis Market worth $6.9 billion by 2029 driven by Technological…
Browse in-depth TOC on "Single Cell Analysis Market" Browse in-depth TOC on "Single Cell Analysis Market" 699 - Tables65 - Figures483 - Pages BD (Becton, Dickinson, and Company): Innovator in Medical Instruments and Reagents BD (Becton, Dickinson, and Company), headquartered in the US, is a prominent developer and distributor of medical instruments and reagents. The company's products cater to various fields including biosciences, diabetes care, respiratory...
PR Newswire
06/08/2024
Multiplex Assays Market to be Worth $6.80 Billion by 2031 - Exclusive Report by…
In a single reaction, multiplex immunoassays measure a large number of various analytes. This is especially useful when only a few samples are collected for examination. Multiplex assays refer to laboratory techniques that allow the simultaneous detection and measurement of multiple analytes or targets within a single sample. These assays are widely used in various scientific and clinical applications due to their efficiency, cost-effectiveness, and ability to generate a wealth of data from a…
PR Newswire
06/08/2024
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August…
If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call. If you are unable to join us live, a recording of the call will be available on our website athttps://investors.imcannabis.com/within 24 hours after the call. Link for the to register for the zoom call:https://us02web.zoom.us/webinar/register/WN_W9nYbBB4R7CREuqN9dGOag About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE:...
PR Newswire
06/08/2024
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides…
ZYNLONTA ®net sales of $17.0 million in 2Q 2024; Commercial profitability achieved during first half of 2024 LOTIS-7 trial enrollment on track with efficacy and safety data on eligible patients expected by year-end 2024 and mature data on all patients expected in first half of 2025Full enrollment in LOTIS-5 trial expected before year-end 2024Company to host conference call today at 8:30 a.m. EDT LAUSANNE, Switzerland, Aug.06, 2024(GLOBE NEWSWIRE) -- ADC Therapeutics SA...
Nasdaq GlobeNewswire
06/08/2024
Altri Comunicati
